Cited by 247Genomics, phytochemicals, and oxidative stressGenetic Neurodegenerative DiseasesNuclear Receptors and Signaling

Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription

Open access
Calkins, Marcus J., Jakel, Rebekah J., Johnson, Delinda A., Chan, Kaimin, Kan, Yuet Wai, Johnson, Jeffrey A.·2005·Proceedings of the National Academy of Sciences

Abstract

Complex II inhibitors 3-nitropropionic acid (3NP) and malonate cause striatal damage reminiscent of Huntington's disease and have been shown to involve oxidative stress in their pathogenesis. Because nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent transcriptional activation by means of the antioxidant response element is known to coordinate the up-regulation of cytoprotective genes involved in combating oxidative stress, we investigated the significance of Nrf2 in complex II-induced toxicity. We found that Nrf2-deficient cells and Nrf2 knockout mice are significantly more vulnerable to malonate and 3NP and demonstrate increased antioxidant response element (ARE)-regulated transcription mediated by astrocytes. Furthermore, ARE preactivation by means of intrastriatal transplantation of Nrf2-overexpressing astrocytes before lesioning conferred dramatic protection against complex II inhibition. These observations implicate Nrf2 as an essential inducible factor in the protection against complex II inhibitor-mediated neurotoxicity. These data also introduce Nrf2-mediated ARE transcription as a potential target of preventative therapy in neurodegenerative disorders such as Huntington's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0408487101

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nrf2-/- mice show profound susceptibility to striatal lesions produced by the mitochondrial complex-II inhibitor malonate.

    “Further, Nrf2-/- mice also show profound susceptibility to striatal lesions produced by the mitochondrial complex-II inhibitor malonate186.”

    From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [186]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 65

  1. [1]Schapira, A. H. (1996) Curr. Opin. Neurol. 9, 260-264. [DOI] [PubMed] [Google Scholar]
  2. [2]Brouillet, E., Conde, F., Beal, M. F. & Hantraye, P. (1999) Prog. Neurobiol. 59, 427-468. [DOI] [PubMed] [Google Scholar]
  3. [3]Huntington's Disease Collaborative Research Group (1993) Cell 72, 971-983. [DOI] [PubMed] [Google Scholar]
  4. [4]Graveland, G. A., Williams, R. S. & DiFiglia, M. (1985) Science 227, 770-773. [DOI] [PubMed] [Google Scholar]
  5. [5]Reiner, A., Albin, R. L., Anderson, K. D., D'Amato, C. J., Penney, J. B. & Young, A. B. (1988) Proc. Natl. Acad. Sci. USA 85, 5733-5737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. [6]Ming, L. (1995) J. Toxicol. Clin. Toxicol. 33, 363-367. [DOI] [PubMed] [Google Scholar]
  7. [7]Liu, X., Luo, X. & Hu, W. (1992) Biomed. Environ. Sci. 5, 161-177. [PubMed] [Google Scholar]
  8. [8]Ludolph, A. C., He, F., Spencer, P. S., Hammerstad, J. & Sabri, M. (1991) Can. J. Neurol. Sci. 18, 492-498. [DOI] [PubMed] [Google Scholar]
  9. [9]Palfi, S., Ferrante, R. J., Brouillet, E., Beal, M. F., Dolan, R., Guyot, M. C., Peschanski, M. & Hantraye, P. (1996) J. Neurosci. 16, 3019-3025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. [10]Bossi, S. R., Simpson, J. R. & Isacson, O. (1993) Neuroreport 4, 73-76. [DOI] [PubMed] [Google Scholar]
  11. [11]Calabrese, V., Scapagnini, G., Giuffrida Stella, A. M., Bates, T. E. & Clark, J. B. (2001) Neurochem. Res. 26, 739-764. [DOI] [PubMed] [Google Scholar]
  12. [12]Browne, S. E., Ferrante, R. J. & Beal, M. F. (1999) Brain Pathol. 9, 147-163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. [13]Beal, M. F. (1995) Ann. Neurol. 38, 357-366. [DOI] [PubMed] [Google Scholar]
  14. [14]Gu, M., Gash, M. T., Mann, V. M., Javoy-Agid, F., Cooper, J. M. & Schapira, A. H. (1996) Ann. Neurol. 39, 385-389. [DOI] [PubMed] [Google Scholar]
  15. [15]Brennan, W. A., Jr., Bird, E. D. & Aprille, J. R. (1985) J. Neurochem. 44, 1948-1950. [DOI] [PubMed] [Google Scholar]
  16. [16]Tabrizi, S. J., Workman, J., Hart, P. E., Mangiarini, L., Mahal, A., Bates, G., Cooper, J. M. & Schapira, A. H. (2000) Ann. Neurol. 47, 80-86. [DOI] [PubMed] [Google Scholar]
  17. [17]Ferrante, R. J., Andreassen, O. A., Dedeoglu, A., Ferrante, K. L., Jenkins, B. G., Hersch, S. M. & Beal, M. F. (2002) J. Neurosci. 22, 1592-1599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. [18]Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., Jenkins, B. G., Ferrante, K. L., Thomas, M., Friedlich, A., Browne, S. E., Schilling, G., Borchelt, D. R., et al. (2001) Neurobiol. Dis. 8, 479-491. [DOI] [PubMed] [Google Scholar]
  19. [19]Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M. & Beal, M. F. (2000) J. Neurosci. 20, 4389-4397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. [20]Schilling, G., Coonfield, M. L., Ross, C. A. & Borchelt, D. R. (2001) Neurosci. Lett. 315, 149-153. [DOI] [PubMed] [Google Scholar]
  21. [21]Zanella, A., Izzo, C., Meola, G., Mariani, M., Colotti, M. T., Silani, V., Pellegata, G. & Scarlato, G. (1980) J. Neurol. Sci. 47, 93-103. [DOI] [PubMed] [Google Scholar]
  22. [22]Kuhl, D. E., Phelps, M. E., Markham, C. H., Metter, E. J., Riege, W. H. & Winter, J. (1982) Ann. Neurol. 12, 425-434. [DOI] [PubMed] [Google Scholar]
  23. [23]Martin, W. R., Hoskinson, M., Kremer, B., Maguire, C. & McEwan, A. (1995) J. Neuroimaging 5, 227-232. [DOI] [PubMed] [Google Scholar]
  24. [24]Antonini, A., Leenders, K. L., Spiegel, R., Meier, D., Vontobel, P., Weigell-Weber, M., Sanchez-Pernaute, R., de Yebenez, J. G., Boesiger, P., Weindl, A. & Maguire, R. P. (1996) Brain 119, Part 6, 2085-2095. [DOI] [PubMed] [Google Scholar]
  25. [25]Hurlbert, M. S., Zhou, W., Wasmeier, C., Kaddis, F. G., Hutton, J. C. & Freed, C. R. (1999) Diabetes 48, 649-651. [DOI] [PubMed] [Google Scholar]
  26. [26]Perez-Severiano, F., Santamaria, A., Pedraza-Chaverri, J., Medina-Campos, O. N., Rios, C. & Segovia, J. (2004) Neurochem. Res. 29, 729-733. [DOI] [PubMed] [Google Scholar]
  27. [27]Wyttenbach, A., Sauvageot, O., Carmichael, J., Diaz-Latoud, C., Arrigo, A. P. & Rubinsztein, D. C. (2002) Hum. Mol. Genet. 11, 1137-1151. [DOI] [PubMed] [Google Scholar]
  28. [28]Reynolds, I. J. & Hastings, T. G. (1995) J. Neurosci. 15, 3318-3327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. [29]Dugan, L. L., Sensi, S. L., Canzoniero, L. M., Handran, S. D., Rothman, S. M., Lin, T. S., Goldberg, M. P. & Choi, D. W. (1995) J. Neurosci. 15, 6377-6388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. [30]Albin, R. L. & Greenamyre, J. T. (1992) Neurology 42, 733-738. [DOI] [PubMed] [Google Scholar]
  31. [31]Jakel, R. J. & Maragos, W. F. (2000) Trends Neurosci. 23, 239-245. [DOI] [PubMed] [Google Scholar]
  32. [32]Maragos, W. F., Jakel, R. J., Pang, Z. & Geddes, J. W. (1998) Exp. Neurol. 154, 637-644. [DOI] [PubMed] [Google Scholar]
  33. [33]Reynolds, D. S., Carter, R. J. & Morton, A. J. (1998) J. Neurosci. 18, 10116-10127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. [34]Nguyen, T., Yang, C. S. & Pickett, C. B. (2004) Free Radical Biol. Med. 37, 433-441. [DOI] [PubMed] [Google Scholar]
  35. [35]Chan, K. & Kan, Y. W. (1999) Proc. Natl. Acad. Sci. USA 96, 12731-12736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. [36]Ramos-Gomez, M., Kwak, M. K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P. & Kensler, T. W. (2001) Proc. Natl. Acad. Sci. USA 98, 3410-3415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. [37]Cho, H. Y., Jedlicka, A. E., Reddy, S. P., Kensler, T. W., Yamamoto, M., Zhang, L. Y. & Kleeberger, S. R. (2002) Am. J. Respir. Cell Mol. Biol. 26, 175-182. [DOI] [PubMed] [Google Scholar]
  38. [38]Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T. & Yamamoto, M. (2001) Toxicol. Sci. 59, 169-177. [DOI] [PubMed] [Google Scholar]
  39. [39]Gao, X. & Talalay, P. (2004) Proc. Natl. Acad. Sci. USA 101, 10446-10451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. [40]Lee, J. M., Shih, A. Y., Murphy, T. H. & Johnson, J. A. (2003) J. Biol. Chem. 278, 37948-37956. [DOI] [PubMed] [Google Scholar]
  41. [41]Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M. & Biswal, S. (2002) Cancer Res. 62, 5196-5203. [PubMed] [Google Scholar]
  42. [42]Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R. M. & Hagen, T. M. (2004) Proc. Natl. Acad. Sci. USA 101, 3381-3386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. [43]Talalay, P. & Fahey, J. W. (2001) J. Nutr. 131, 3027S-3033S. [DOI] [PubMed] [Google Scholar]
  44. [44]Zhang, Y. & Gordon, G. B. (2004) Mol. Cancer Ther. 3, 885-893. [PubMed] [Google Scholar]
  45. [45]Ohtsubo, T., Kamada, S., Mikami, T., Murakami, H. & Tsujimoto, Y. (1999) Cell Death Differ. 6, 865-872. [DOI] [PubMed] [Google Scholar]
  46. [46]Kotlo, K. U., Yehiely, F., Efimova, E., Harasty, H., Hesabi, B., Shchors, K., Einat, P., Rozen, A., Berent, E. & Deiss, L. P. (2003) Oncogene 22, 797-806. [DOI] [PubMed] [Google Scholar]
  47. [47]Cullinan, S. B. & Diehl, J. A. (2004) J. Biol. Chem. 279, 20108-20117. [DOI] [PubMed] [Google Scholar]
  48. [48]Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J. & Diehl, J. A. (2003) Mol. Cell. Biol. 23, 7198-7209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. [49]Lee, J. M., Calkins, M. J., Chan, K., Kan, Y. W. & Johnson, J. A. (2003) J. Biol. Chem. 278, 12029-12038. [DOI] [PubMed] [Google Scholar]
  50. [50]Shih, A. Y., Johnson, D. A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A. & Murphy, T. H. (2003) J. Neurosci. 23, 3394-3406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. [51]Kraft, A. D., Johnson, D. A. & Johnson, J. A. (2004) J. Neurosci. 24, 1101-1112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. [52]Li, J., Stein, T. D. & Johnson, J. A. (2004) Physiol. Genomics 18, 261-272. [DOI] [PubMed] [Google Scholar]
  53. [53]Chan, K., Lu, R., Chang, J. C. & Kan, Y. W. (1996) Proc. Natl. Acad. Sci. USA 93, 13943-13948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. [54]Johnson, D. A., Andrews, G. K., Xu, W. & Johnson, J. A. (2002) J. Neurochem. 81, 1233-1241. [DOI] [PubMed] [Google Scholar]
  55. [55]Gabrielson, K. L., Hogue, B. A., Bohr, V. A., Cardounel, A. J., Nakajima, W., Kofler, J., Zweier, J. L., Rodriguez, E. R., Martin, L. J., de Souza-Pinto, N. C. & Bressler, J. (2001) Am. J. Pathol. 159, 1507-1520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. [56]Fernagut, P. O., Diguet, E., Stefanova, N., Biran, M., Wenning, G. K., Canioni, P., Bioulac, B. & Tison, F. (2002) Neuroscience 114, 1005-1017. [DOI] [PubMed] [Google Scholar]
  57. [57]Olsen, C., Rustad, A., Fonnum, F., Paulsen, R. E. & Hassel, B. (1999) Brain Res. 850, 144-149. [DOI] [PubMed] [Google Scholar]
  58. [58]Petit, A., Pierret, P., Vallee, A. & Doucet, G. (2001) J. Neurosci. 21, 7182-7193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. [59]Ramos-Gomez, M., Dolan, P. M., Itoh, K., Yamamoto, M. & Kensler, T. W. (2003) Carcinogenesis 24, 461-467. [DOI] [PubMed] [Google Scholar]
  60. [60]Chan, K., Han, X. D. & Kan, Y. W. (2001) Proc. Natl. Acad. Sci. USA 98, 4611-4616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. [61]Lee, J. M., Chan, K., Kan, Y. W. & Johnson, J. A. (2004) Proc. Natl. Acad. Sci. USA 101, 9751-9756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. [62]Yoh, K., Itoh, K., Enomoto, A., Hirayama, A., Yamaguchi, N., Kobayashi, M., Morito, N., Koyama, A., Yamamoto, M. & Takahashi, S. (2001) Kidney Int. 60, 1343-1353. [DOI] [PubMed] [Google Scholar]
  63. [63]Bizat, N., Hermel, J. M., Boyer, F., Jacquard, C., Creminon, C., Ouary, S., Escartin, C., Hantraye, P., Kajewski, S. & Brouillet, E. (2003) J. Neurosci. 23, 5020-5030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. [64]Kim, G. W. & Chan, P. H. (2002) J. Cereb. Blood Flow Metab. 22, 798-809. [DOI] [PubMed] [Google Scholar]
  65. [65]Kim, Y. S. (2002) J. Biochem. Mol. Biol. 35, 443-451. [DOI] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Calkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W., & Johnson, J. A.
Affiliations
University of Wisconsin–Madison (US)
Venue
Proceedings of the National Academy of Sciences
Published
2004-12-20
Volume
102
Issue
1
Pages
244-249
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1986070505
Cited by
247
References
68
Citations by year
2026: 1 · 2025: 6 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 6 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 10 · 2016: 15 · 2015: 12 · 2014: 21 · 2013: 12 · 2012: 21
FWCI
2.96
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK16666, R01DK016666, R37DK016666)
  • National Institute of Environmental Health Sciences (ES-07015, ES10042, R01ES010042, ES08089, R01ES008089, R29ES008089, T32ES007015)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
Nrf2, mitochondrial complex II inhibition, 3-nitropropionic acid, malonate, Huntington's disease, oxidative stress, antioxidant response element, astrocytes, striatal neurotoxicity, Nrf2 knockout mice, neuroprotection, neurodegenerative disease treatment
MeSH terms
Animals, Astrocytes, DNA-Binding Proteins, Humans, Malonates, Nitro Compounds, Propionates, Succinate Dehydrogenase, Transcription, Genetic, Trans-Activators, Genes, Reporter, NF-E2-Related Factor 2, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review